Cargando…
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic Colitis
BACKGROUND: Microscopic colitis (MC) is suspected to result from increased immune activity in gut mucosa. Immune checkpoint inhibitors (ICIs) treat cancer by activating the immune system, and further investigation is needed regarding their role in the development of MC. METHODS: A retrospective case...
Autores principales: | Fredrick, Thomas W, Ramos, Guilherme P, Braga Neto, Manuel B, Kane, Sunanda, Faubion, William A, Loftus, Edward V, Pardi, Darrell S, Pasha, Shabana F, Farraye, Francis A, Zhang, Lizhi, Raffals, Laura E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802423/ https://www.ncbi.nlm.nih.gov/pubmed/36777041 http://dx.doi.org/10.1093/crocol/otac008 |
Ejemplares similares
-
Case report: Pentoxifylline treatment in microscopic colitis
por: Cotter, Thomas G., et al.
Publicado: (2017) -
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience
por: Ramos, Guilherme Piovezani, et al.
Publicado: (2021) -
Microscopic colitis: Etiopathology, diagnosis, and rational management
por: Nielsen, Ole Haagen, et al.
Publicado: (2022) -
The natural history of histological changes in microscopic
colitis
por: Sehgal, Kanika, et al.
Publicado: (2023) -
The Combination of Patient-Reported Clinical Symptoms and an Endoscopic Score Correlates Well with Health-Related Quality of Life in Patients with Ulcerative Colitis
por: Aniwan, Satimai, et al.
Publicado: (2019)